[Hemostatic disorders in thyrotoxicosis and their correction].
D013956:Antithyroid Agents / Q000627:therapeutic use; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000209:etiology / Q000628:therapy*; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D001803:Blood Transfusion; D002199:Capillary Permeability; D005342:Fibrinolysis; D006042:Goiter / Q000503:physiopathology; D006474:Hemorrhagic Disorders / Q000628:therapy; D006487:Hemostasis; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D013921:Thrombocytopenia / Q000503:physiopathology; D013961:Thyroid Gland / Q000503:physiopathology; D013963:Thyroid Hormones / Q000502:physiology
D013956:Antithyroid Agents; D001779:Blood Coagulation Factors; D013963:Thyroid Hormones
Narusheniia gemostaza pri tireotoksikoze i ikh korrektsiia.